Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...

Mobile stroke units (MSU) enable rapid identification and treatment of thrombolytic-eligible patients with acute ischemic stroke (AIS). Recent studies have highlighted the benefit of MSUs over ...

Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

Shares of Japan's Sumitomo Pharma fell over 15%. Japanese government endorsed the company's iPS cell-based therapy for Parkinson's and heart disease. Shares of Japanese drugmaker Sumitomo Pharma fell ...

TOKYO, Feb 19 (Reuters) - Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's (4506.T), opens new tab iPS cell-derived treatment for Parkinson's disease, ...

NYU Langone Health, a major Manhattan hospital, will permanently ax its transgender treatment program for kids after the Trump administration threatened to pull federal funding. The hospital is ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The warning on the government website was stark. Some ...

NYU Langone Health cited the “current regulatory environment” in its decision to discontinue its gender medicine program for minors. By Joseph Goldstein A major Manhattan hospital, faced with threats ...

An optometrist provides an eye exam to a VA beneficiary in 2022 at Fort Meade, Maryland. (Michelle Gonzalez/U.S. Army) Veterans Affairs medical examiners are now required to consider the effects of ...

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a ...

Minoxidil and finasteride are two FDA-approved medications considered the gold standard for treating hair loss. Other treatments like low-level light therapy, PRP injections, and supplements may also ...